Portfolio company
DoMore Diagnostics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops artificial intelligence software for digital pathology to help oncologists and pathologists provide personalised cancer treatment paths for patients.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
AI Pathology
This company develops artificial intelligence software for cancer diagnosis and digital pathology image analysis to support pathologists and laboratories.
Ibex Medical
This company develops artificial intelligence software for cancer diagnostics to assist pathologists in labs and hospitals with biopsy analysis and quality control.
Qritive
This company develops AI software modules and a digital workbench to help pathologists and hospitals identify, grade and classify cancer from medical images.
Persona-Dx
The company develops artificial intelligence biomarker tests for tissue and blood samples to help oncologists personalise cancer diagnosis and treatment for metastatic patients.
Ibex Medical Analytics
This company develops artificial intelligence platforms for cancer diagnostics to assist pathologists and laboratories with automated biopsy analysis and clinical workflows.
Waiv
This company develops artificial intelligence diagnostic tests and digital pathology software for oncology laboratories and healthcare providers to improve cancer patient treatment decisions.
Proscia
This company develops a digital pathology platform and artificial intelligence software for laboratories, hospitals and biopharmaceutical organisations.
StratifAI
This company develops multimodal artificial intelligence biomarkers to predict cancer recurrence risks from pathology slides for oncologists and pharmaceutical organisations.
